NUVALENT INC's ticker is and the CUSIP is 670703107. A total of 92 filers reported holding NUVALENT INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.5%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 19,991,024 | $843,021,482 | 18.00% |
| Fairmount Funds Management LLC | 2,884,492 | $121,639,028 | 17.15% |
| Bain Capital Life Sciences Investors, LLC | 3,577,267 | $150,853,349 | 15.54% |
| COMMODORE CAPITAL LP | 1,150,000 | $48,495,500 | 5.45% |
| Paradigm Biocapital Advisors LP | 1,120,465 | $47,250,009 | 3.65% |
| Perceptive Advisors | 2,194,821 | $92,555,602 | 2.68% |
| Boxer Capital, LLC | 1,210,192 | $51,034 | 2.37% |
| Ikarian Capital, LLC | 272,752 | $11,501,952 | 1.83% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 115,067 | $4,852,375 | 1.50% |
| HighVista Strategies LLC | 72,298 | $3,048,807 | 1.40% |